Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a ...
Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a ...
Source: pr-inside.com
Stay updated with breaking news from Jill Jene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a ...
/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on neuroendocrine and metabolic disorders, announced today the appointment of...